GilteRInf 2022 Study (Gilteritinib Related Infections)

NCT05791890 · clinicaltrials.gov ↗

UNKNOWN

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Gilteritinib

Sponsor

University of Rome Tor Vergata